Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Hayes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Hand Surgery|March 6, 2012
Additional considerations in complex regional pain syndromePeter J Hayes, Dean S Louis, Morton L Kasdan
JAMA Dermatology|May 9, 2014
New blue-black nodule in a patient with a history of melanomaPeter J Hayes, Janine C Malone, Timothy S Brown
Pediatric Dermatology|January 25, 2019
A case of penile swelling in a 6-year-old boyTejesh Patel, Teresa S Wright, Peter J Hayes, et al.
AJP Reports|July 5, 2017
Recurrent Staphylococcal Scalded Skin Syndrome in an Extremely Low-Birth-Weight NeonateJennifer Davidson, Samantha Polly, Peter J Hayes, et al.
The Science of the Total Environment|October 26, 2002
Localised remobilization of metals in a marine sedimentHao Zhang, William Davison, Robert J G Mortimer, et al.
The Journal of Infectious Diseases|April 4, 2002
Elevated mucosal addressin cell adhesion molecule-1 expression in acquired immunodeficiency syndrome is maintained during antiretroviral therapy by intestinal pathogens and coincides with increased duodenal CD4 T cell densitiesYin M Miao, Peter J Hayes, Frances M Gotch, et al.
Orthopedics|August 14, 2013
Operative treatment of acetabular fractures in the Medicare populationPeter J Hayes, Colin M Carroll, Craig S Roberts, et al.
AIDS (London, England)|April 19, 2016
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibitionPeter J Hayes, Josephine H Cox, Adam R Coleman, et al.
The Lancet. Microbe|November 29, 2024
Safety and immunogenicity of the ChAdOx1-MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UKNicola Borthwick, Natalia Fernandez, Peter J Hayes, et al.
Frontiers in Immunology|March 10, 2017
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization RegimesSarah Joseph, Killian Quinn, Aldona Greenwood, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Hand Surgery|March 6, 2012
Additional considerations in complex regional pain syndromePeter J Hayes, Dean S Louis, Morton L Kasdan
JAMA Dermatology|May 9, 2014
New blue-black nodule in a patient with a history of melanomaPeter J Hayes, Janine C Malone, Timothy S Brown
Pediatric Dermatology|January 25, 2019
A case of penile swelling in a 6-year-old boyTejesh Patel, Teresa S Wright, Peter J Hayes, et al.
AJP Reports|July 5, 2017
Recurrent Staphylococcal Scalded Skin Syndrome in an Extremely Low-Birth-Weight NeonateJennifer Davidson, Samantha Polly, Peter J Hayes, et al.
The Science of the Total Environment|October 26, 2002
Localised remobilization of metals in a marine sedimentHao Zhang, William Davison, Robert J G Mortimer, et al.
The Journal of Infectious Diseases|April 4, 2002
Elevated mucosal addressin cell adhesion molecule-1 expression in acquired immunodeficiency syndrome is maintained during antiretroviral therapy by intestinal pathogens and coincides with increased duodenal CD4 T cell densitiesYin M Miao, Peter J Hayes, Frances M Gotch, et al.
Orthopedics|August 14, 2013
Operative treatment of acetabular fractures in the Medicare populationPeter J Hayes, Colin M Carroll, Craig S Roberts, et al.
AIDS (London, England)|April 19, 2016
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibitionPeter J Hayes, Josephine H Cox, Adam R Coleman, et al.
The Lancet. Microbe|November 29, 2024
Safety and immunogenicity of the ChAdOx1-MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UKNicola Borthwick, Natalia Fernandez, Peter J Hayes, et al.
Frontiers in Immunology|March 10, 2017
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization RegimesSarah Joseph, Killian Quinn, Aldona Greenwood, et al.
Pageof 1